Medicare Enrolled

Dr. Jacob Templin, DO

Internal Medicine · Dayton, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1012 S 3RD ST., Dayton, WA 99328
5093828347
In practice since 2014 (12 years)
NPI: 1295149052 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Templin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Templin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Templin

Dr. Jacob Templin is an internal medicine specialist in Dayton, WA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Templin performed 1,837 Medicare services across 194 unique beneficiaries.

Between the years covered by Open Payments, Dr. Templin received a total of $2,404 from 34 pharmaceutical and/or device companies across 122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Templin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 8% volume in WA $2,404 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,837
Medicare services
Top 8% in WA for internal medicine
194
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~153 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,560 $18 $35
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
77 $7 $20
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
52 $11 $61
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
37 $8 $20
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
29 $9 $93
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
26 $8 $60
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
21 $52 $192
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
19 $10 $39
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
16 $16 $95
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
91.9% medium
6.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,404
Total received (2018-2024)
Avg $343/year across 7 years
Top 18% in WA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
122
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,404 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$756
2023
$575
2022
$588
2021
$280
2020
$14
2019
$130
2018
$61

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$281
Novartis Pharmaceuticals Corporation
$168
Corcept Therapeutics
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
PFIZER INC.
$39
Lundbeck LLC
$34
AstraZeneca Pharmaceuticals LP
$32
Dexcom, Inc.
$23
Novo Nordisk Inc
$22
Phathom Pharmaceuticals, Inc.
$19
Exact Sciences Corporation
$18
Philips North America LLC
$15
Top 3 companies account for 67.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$448
AbbVie Inc.
$282
Novartis Pharmaceuticals Corporation
$231
Boehringer Ingelheim Pharmaceuticals, Inc.
$227
Bayer HealthCare Pharmaceuticals Inc.
$171
AstraZeneca Pharmaceuticals LP
$93
PFIZER INC.
$92
SANOFI-AVENTIS U.S. LLC
$88
Exact Sciences Corporation
$79
Corcept Therapeutics
$57
SANOFI PASTEUR INC.
$54
Daiichi Sankyo Inc.
$51
GlaxoSmithKline, LLC.
$42
Mylan Specialty L.P.
$37
Merck Sharp & Dohme LLC
$37
Lundbeck LLC
$34
Merck Sharp & Dohme Corporation
$33
Biohaven Pharmaceutical Holding Company Ltd.
$28
Bayer Healthcare Pharmaceuticals Inc.
$28
Otsuka America Pharmaceutical, Inc.
$28
Sunovion Pharmaceuticals Inc.
$28
Astellas Pharma US Inc
$27
Shionogi Inc
$25
Kowa Pharmaceuticals America, Inc.
$24
Dexcom, Inc.
$23
Novo Nordisk Inc
$22
Janssen Pharmaceuticals, Inc
$19
Phathom Pharmaceuticals, Inc.
$19
Gilead Sciences, Inc.
$15
Philips North America LLC
$15
Circassia Pharmaceuticals Inc
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$11
Amgen Inc.
$11
Celgene Corporation
$11
Top 3 companies account for 40.0% of all-time payments
Associated products mentioned in payments ›
(CK4) MCOT · AIRSUPRA · BREZTRI · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · GARDASIL 9 · GEMTESA · INJECTAFER · JARDIANCE · Kerendia · Korlym · LEQVIO · LONHALA MAGNAIR · Livalo · Mulpleta · NURTEC ODT · OFEV · Ozempic · Prolia · QULIPTA · RELISTOR ORAL · REXULTI · SHINGRIX · SOLIQUA 100/33 · SYMBICORT · TOUJEO · TRELEGY ELLIPTA · TUDORZA PRESSAIR · UBRELVY · VOQUEZNA · VRAYLAR · Veozah · XARELTO · YUPELRI · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Dayton?
Compare internal medicine physicians in the Dayton area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
41
Per 100K population
1026.0
County median income
$71,528
Nearest hospital
DAYTON GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Templin is a mixed practice specialist, with above-average Medicare volume (top 8% in WA), with low-engagement industry engagement in the top 18% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Templin experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Templin performed 1,560 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Templin receive payments from pharmaceutical companies?
Yes. Dr. Templin received a total of $2,404 from 34 companies across 122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Templin's costs compare to other internal medicine physicians in Dayton?
Dr. Templin's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Templin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →